ArticleGeroScience2026
BRAIN-DISC: a novel analytical approach integrating data-driven brain pattern discovery with cohort studies for evaluating findings in brain modulation interventions.
Article in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Brain modulation interventions (BMIs) targeting cognitive and neuropsychiatric symptoms have shown substantial heterogeneity in response, limiting their clinical utility. Resting-state functional connectivity (rsFC) may capture BMI-induced neuroplasticity and support patient stratification. However, examining these biomarkers within small, heterogeneous intervention samples remains challenging. The objective of this study is to present BRAIN-DISC, an analytic framework that links large-scale cohort-derived rsFC patterns with evaluation in targeted BMI trials. Three demonstrations were conducted. In the CogTE trial (n = 74), the Alzheimer's-resilient connectome (ARC), derived from cohort contrasts of Superagers and Alzheimer's disease, was evaluated as a response biomarker for cognitive training in mild cognitive impairment (MCI). In the BEEM trial (n = 26), a brain-derived neuropsychiatric phenotyping (BNP) subtype was used to stratify response to transcranial direct current stimulation combined with training. In a third demonstration, we conducted an end-to-end implementation by discovering rsFC biotypes jointly informed by autonomic nervous system (ANS) and cognitive function (rsFC-AC) in the MIDUS cohort (n = 208), and evaluating it as a predictive biomarker in BREATHE trial (n = 56). In CogTE, greater shifts toward the ARC pattern were associated with improvements in executive function and episodic memory. In BEEM, individuals with the affective dysregulation subtype showed greater improvement in corresponding neuropsychiatric domains. In the third demo, three rsFC-AC biotypes were discovered in MIDUS cohort; the high-ANS subtype showed greater improvement in episodic memory in BREATHE trial. BRAIN-DISC provides a scalable framework for translating cohort-derived rsFC signatures into intervention settings to support both response monitoring and patient stratification.
Indexed as
Identifiers
42625098What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.